InVivo NSA has acquired AdGène
InVivo NSA has acquired AdGène for US$8 million.
InVivo NSA, along with its subsidiaries, engages in complete feed, premix, additives, analysis laboratories, and animal health businesses in Central America, South America, France/EMEA, and Asia. InVivo Labs, the analytical division of InVivo NSA, and AdGène, an expert laboratory in molecular biology in France, have announced their strategic union. This transaction allows InVivo Labs to reinforce its analytical portfolio related to food safety and traceability. Moreover, it positions the new group as a significant player in the high potential growing market of bioanalysis.
Founded in 2001, AdGène is a French laboratory that specializes in molecular biology, genetic analyses and water quality control. The laboratory employs 20 people and has high-tech equipment.
Oaklins' team in France advised the buyer in this transaction.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreArtisJP has sold 500 ha of farmland to the Land Fund of Latvia
ArtisJP has sold 500 hectares of agricultural land in the Ventspils region of western Latvia to the Land Fund of Latvia, managed by the Latvian state finance institution Altum.
Learn moreAYANDA CAPITAL has added a new investor to its shareholding
A new investor, Thierry Jacobs, has joined AYANDA CAPITAL S.L.’s shareholding with a minority stake.
Learn more